Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?

@article{Pendyala2014DoesBH,
  title={Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?},
  author={Lakshmana K Pendyala and Joshua Ping Yun Loh and Thibault Lhermusier and Sa'ar Minha and Marco Antonio Magalh{\~a}es and Rebecca L Torguson and Fang Quan Chen and Lowell F Satler and Augusto D. Pichard and Ron Waksman},
  journal={American heart journal},
  year={2014},
  volume={168 4},
  pages={
          545-51
        }
}
  • Lakshmana K Pendyala, Joshua Ping Yun Loh, +7 authors Ron Waksman
  • Published in American heart journal 2014
  • Medicine
  • BACKGROUND High on-treatment platelet reactivity (HTPR) has been shown to be associated with adverse cardiac events in patients undergoing percutaneous coronary intervention, but the effect of baseline hematologic parameters upon platelet reactivity remains controversial. OBJECTIVE The present study aims to evaluate the impact of hematocrit on 2 different assay methods used to assess on-treatment platelet reactivity to clopidogrel. METHODS We tested clopidogrel on-treatment platelet… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-7 OF 7 CITATIONS

    Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients

    VIEW 2 EXCERPTS
    CITES RESULTS & BACKGROUND